10 results
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
employees are subject to a collective bargaining agreement. We consider our relationship with our employees to be good. In addition, as of December 31, 2023
424B3
NAMS
NewAmsterdam Pharma Company NV
15 Aug 23
Prospectus supplement
4:52pm
are subject to a collective bargaining agreement. We consider our relationship with our employees to be good. We have also engaged consultants to assist
POS AM
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
, regulatory, finance and operational personnel. None of our employees are subject to a collective bargaining agreement. We consider our relationship with our
424B3
NAMS
NewAmsterdam Pharma Company NV
8 Jun 23
Prospectus supplement
5:01pm
and operational personnel. None of our employees are subject to a collective bargaining agreement. We consider our relationship with our employees
424B3
NAMS
NewAmsterdam Pharma Company NV
6 Jun 23
Prospectus supplement
4:20pm
. None of our employees are subject to a collective bargaining agreement. We consider our relationship with our employees to be good. We have also engaged
424B3
wjxw7oys4mkdl07f
25 Apr 23
Prospectus supplement
8:14am
POS AM
fvpqyc39n ek6p
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
cb26ba1q
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-2.1
xlct2
23 Nov 22
Current report (foreign)
4:36pm
- Prev
- 1
- Next